PT Dosni Roha Indonesia Tbk, through its subsidiaries, (ZBRA) Fair Value & Analysis
Healthcare · ID · Market cap 26.7B IDR
Fair value as of: Jul 13, 2026
From 13 valuation models · updated today
Fair value updated Jul 13, 2026 — revised from 7,410 IDR to 423.66 IDR (−94.3%) since Jun 24, 2026.
Price vs Fair Value (12 months)
12‑month range 50.00 IDR – 50.00 IDR · fair‑value band 423.66 IDR – 1,041 IDR · the 50.00 IDR price screens below the 423.66 IDR fair value. As of Jul 13, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
PT Dosni Roha Indonesia Tbk, through its subsidiaries, (ZBRA) currently trades at 50.00 IDR, while our model-based Fair Value estimate is 423.66 IDR — implying the stock looks roughly 747.3% undervalued today. We read business quality at 41/100 (below-average quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.
Over the trailing twelve months, PT Dosni Roha Indonesia Tbk, through its subsidiaries, generated revenue of 941B IDR at a net margin of -33.6%. Revenue declined 89.5% year over year. It earns a return on equity of -28.3%. Net debt stands at 1.1T IDR. Fundamentals as of Jul 13, 2026
Our scenario range runs from 423.66 IDR (bear case) to 1,041 IDR (bull case); at 50.00 IDR, the current price sits below that range. The share trades near its 52-week high, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at 21% fair-value upside — at 747%, ZBRA screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 13, 2026. TTM = trailing twelve months.
About the company
PT Dosni Roha Indonesia Tbk, through its subsidiaries, engages in trading, export-import, logistic, and information technology (IT) businesses in Indonesia. It operates through Logistics, Technology and Information, Medical Equipment Trade, and Others segment. The company distributes health care and consumer goods; and provides freight forwarding and warehousing. It also offers transportation management services; marketing goods; and courier and other business support services. The company was formerly known as PT Zebra Nusantara Tbk and changed its name to PT Dosni Roha Indonesia Tbk in March 2022. PT Dosni Roha Indonesia Tbk was founded in 1987 and is headquartered in Jakarta Selatan, Indonesia. PT Dosni Roha Indonesia Tbk operates as a subsidiary of PT Trinity Healthcare.
Revenue & earnings trend
FY2019 – FY2023 · reported fiscal years
PT Dosni Roha Indonesia Tbk, through its subsidiaries, reported revenue of 1.7T IDR in FY2023 versus 15.7B IDR in FY2019, a compound +223.7%/yr. Reported net income was −139B IDR in FY2023.
Is ZBRA fairly valued? → Check now
Similar stocks
10 more Medical Distribution stocks, each showing price versus our Fair Value estimate (as of Jul 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| McKesson Corporation M1CK34 | R$999.49 | R$1,236 | +24% |
| Cencora, Inc COR | $271.28 | $175.74 | -35% |
| Cardinal Health, Inc CAH | $201.74 | $92.07 | -54% |
| Sigma Healthcare Limited SIGGF | $2.35 | $0.7800 | -67% |
| Shanghai Pharmaceuticals Holding 601607 | ¥15.96 | ¥45.15 | +183% |
| Henry Schein, Inc HSIC | $78.67 | $67.77 | -14% |
| Galenica AG GALNF | $115.00 | $98.28 | -15% |
| Guangzhou Baiyunshan Pharmaceutical Holdings 600332 | ¥20.81 | ¥25.18 | +21% |
| Medipal Holdings MEPDF | $18.35 | $29.88 | +63% |
| Jointown Pharmaceutical Group 600998 | ¥4.87 | ¥9.24 | +90% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is PT Dosni Roha Indonesia Tbk, through its subsidiaries, (ZBRA) undervalued?
What is the fair value of ZBRA?
What is the quality score of ZBRA?
What is the revenue of PT Dosni Roha Indonesia Tbk, through its subsidiaries, (ZBRA)?
What is the net profit margin of ZBRA?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Unlock the full PT Dosni Roha Indonesia Tbk, through its subsidiaries, analysis — and try Pro free
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.